AR082141A1 - Derivados xantenodiona para el tratamiento de trastornos de pigmentacion y de envejecimiento de la piel - Google Patents

Derivados xantenodiona para el tratamiento de trastornos de pigmentacion y de envejecimiento de la piel

Info

Publication number
AR082141A1
AR082141A1 ARP110102461A ARP110102461A AR082141A1 AR 082141 A1 AR082141 A1 AR 082141A1 AR P110102461 A ARP110102461 A AR P110102461A AR P110102461 A ARP110102461 A AR P110102461A AR 082141 A1 AR082141 A1 AR 082141A1
Authority
AR
Argentina
Prior art keywords
radical
treatment
xantenodiona
pigmentation
derivatives
Prior art date
Application number
ARP110102461A
Other languages
English (en)
Original Assignee
Fabre Pierre Dermo Cosmetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fabre Pierre Dermo Cosmetique filed Critical Fabre Pierre Dermo Cosmetique
Publication of AR082141A1 publication Critical patent/AR082141A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/69—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/08—Preparations for bleaching the hair
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Compuesto de fórmula (1) genérica, en donde R1 y R2 representan: OH, un átomo de hidrógeno, un radical alquilo C1-6, alcoxi C1-6, halógeno, u OCOR3; R3 representa un radical alquilo C1-24, alquenilo C12-24 que comprende por lo menos una insaturación; R4 representa: COR5, un glúcido sustituido o no por uno o más radical(es) acetilo; R5 representa: un radical alquilo C10-24, o un radical alquenilo C12-24 que comprende por lo menos una insaturación entre 1 a 4; R6 y R7 representan simultáneamente un átomo de hidrógeno o un radical metilo, o cuando R6 representa un átomo de hidrógeno, R7 representa un radical alquilo C1-6 o un fenilo sustituido o no por uno o más radical(es) alcoxi C1-3 o uno o más halógeno(s); o R6 y R7 están unidos juntos y forman un cicloalquilo C3-6, y sales aceptables desde el punto de vista farmacéutico o cosmético. Se proveen además, método para su preparación, composiciones farmacéuticas que lo comprenden y su uso en el tratamiento del envejecimiento y/o la inflamación de la piel.
ARP110102461A 2010-07-09 2011-07-08 Derivados xantenodiona para el tratamiento de trastornos de pigmentacion y de envejecimiento de la piel AR082141A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1055595A FR2962436B1 (fr) 2010-07-09 2010-07-09 Derives de xanthedediones pour le traitement des troubles de la pigmentation et du vieillissement cutane

Publications (1)

Publication Number Publication Date
AR082141A1 true AR082141A1 (es) 2012-11-14

Family

ID=43759812

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110102461A AR082141A1 (es) 2010-07-09 2011-07-08 Derivados xantenodiona para el tratamiento de trastornos de pigmentacion y de envejecimiento de la piel

Country Status (20)

Country Link
US (1) US8906416B2 (es)
EP (1) EP2590959A1 (es)
JP (1) JP5829272B2 (es)
KR (1) KR20130043181A (es)
CN (1) CN102985415B (es)
AR (1) AR082141A1 (es)
AU (1) AU2011275686B2 (es)
BR (1) BR112013000431A2 (es)
CA (1) CA2804334A1 (es)
FR (1) FR2962436B1 (es)
HK (1) HK1178521A1 (es)
IL (1) IL224123A (es)
MA (1) MA34390B1 (es)
MX (1) MX2013000077A (es)
NZ (1) NZ605750A (es)
RU (1) RU2598374C2 (es)
SG (1) SG186941A1 (es)
TW (1) TWI538693B (es)
WO (1) WO2012004390A1 (es)
ZA (1) ZA201300413B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014142127A1 (ja) * 2013-03-12 2014-09-18 第一三共株式会社 フェニルキサンテン誘導体

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU895985A1 (ru) * 1980-03-27 1982-01-07 Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латвсср 9-Ароил-3,3,6,6-тетраметил-1,2,3,4,5,6,7,8-октагидроксантен-1,8-дионы в качестве промежуточных продуктов дл синтеза соединений,обладающих антиоксидантной активностью
JP3498857B2 (ja) * 1994-01-28 2004-02-23 株式会社ノエビア 皮膚外用剤
GB9707695D0 (en) * 1996-08-07 1997-06-04 Hoffmann La Roche Tricyclic dione derivatives
US7390668B2 (en) * 1996-10-30 2008-06-24 Provectus Pharmatech, Inc. Intracorporeal medicaments for photodynamic treatment of disease
FR2756183B1 (fr) * 1996-11-25 1999-08-27 Fabre Pierre Dermo Cosmetique Association d'huile et de peptides d'argan utile pour le traitement des troubles lies au vieillissement cutane
EP2020242B1 (en) * 1999-08-13 2011-10-19 Provectus Pharmatech, Inc. Improved Topical Medicaments and Methods for Photodynamic Treatment of Disease
EP1213025A1 (de) * 2000-12-06 2002-06-12 Laboratoires Serobiologiques(Societe Anonyme) Kosmetische und/oder dermopharmazeutische Zubereitungen enthaltend Extrakte aus den Blättern der Pflanze Argania spinosa
GB0215534D0 (en) * 2002-07-04 2002-08-14 Ecole Polytech Selective photochemotherapy using oligonucleotide targeting agents
WO2006055688A1 (en) * 2004-11-16 2006-05-26 Renaissance Herbs, Inc. Pharmaceutical and therapeutic compositions derived from garcinia mangostana l plant

Also Published As

Publication number Publication date
CN102985415B (zh) 2015-07-01
EP2590959A1 (en) 2013-05-15
CA2804334A1 (en) 2012-01-12
US20130108568A1 (en) 2013-05-02
TW201206488A (en) 2012-02-16
JP2013530203A (ja) 2013-07-25
IL224123A (en) 2016-06-30
TWI538693B (zh) 2016-06-21
JP5829272B2 (ja) 2015-12-09
AU2011275686B2 (en) 2014-11-27
KR20130043181A (ko) 2013-04-29
FR2962436B1 (fr) 2012-12-14
RU2598374C2 (ru) 2016-09-27
HK1178521A1 (en) 2013-09-13
RU2013103030A (ru) 2014-08-20
SG186941A1 (en) 2013-02-28
AU2011275686A1 (en) 2013-01-31
US8906416B2 (en) 2014-12-09
CN102985415A (zh) 2013-03-20
MA34390B1 (fr) 2013-07-03
FR2962436A1 (fr) 2012-01-13
MX2013000077A (es) 2013-03-18
ZA201300413B (en) 2013-09-25
WO2012004390A1 (en) 2012-01-12
NZ605750A (en) 2015-12-24
BR112013000431A2 (pt) 2016-05-17

Similar Documents

Publication Publication Date Title
AR077413A1 (es) Derivados piridin-4-ilo
AR081337A1 (es) Derivados de 1,4-benzotiazepinas, composiciones farmaceuticas que los comprenden y su uso en la preparacion de un medicamento para el tratamiento de trastornos metabolicos
SV2009003376A (es) Derivados de aril isoxazolinas insecticidas
SV2008003088A (es) Nueva forma cristalina vi de la agomelatina, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen
DOP2014000133A (es) Triazolopiridinas sustituidas
ECSP12011935A (es) Triazolopiridinas
CU20110145A7 (es) Derivados de sulfonamida
UY32490A (es) Inhibidores de beta-secretasa
CO6620055A2 (es) Ciertas amino-pirimidinas, composiciones de las mismas y métodos para el uso de los mismos
SV2011003802A (es) Derivados de triazol utiles para el tratamiento de enfermedades
CL2012001911A1 (es) Compuestos derivados de fumarato; composicion farmaceutica que los comprende; y su uso en el tratamiento de una enfermedad inflamatoria o neurodegenerativa.
ECSP12012338A (es) Triazolopiridinas sustituidas
CR20140134A (es) Composiciones farmacéuticas
AR074341A1 (es) Derivados heterociclicos de isoindol, inhibidores de proteinasas bace, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento y/o prevencion de patologias relacionadas a deficiencias cognitivas, tales como alzheimer.
AR076181A1 (es) Compuestos derivados de mentol y uso de los mismos como agentes activos orales y sistemicos. metodo. composicion.
EA201171339A1 (ru) Способ снижения внутриглазного давления у людей
AR074453A1 (es) Compuestos 4-(azacicloalquil ) benceno-1,3-diol, como inhibidores de la tirosinasa y su uso en medicina humana y tambien en cosmetica
BR112015004523A2 (pt) compostos de tetraciclina
GT201300322A (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib
IN2014DN02926A (es)
AR081966A1 (es) Derivados aminoester de alcaloides y composicion medicinal de los mismos
UY32744A (es) Derivados de 2-carboxamida-7-piperazinil-benzofurano 774
AR084883A1 (es) Derivados de 2-metoxi-piridin-4-ilo
AR082141A1 (es) Derivados xantenodiona para el tratamiento de trastornos de pigmentacion y de envejecimiento de la piel
AR077429A1 (es) Compuestos hidroxiasenapina sus derivados y composiciones farmaceuticas que comprenden los mismos

Legal Events

Date Code Title Description
FB Suspension of granting procedure